Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems.
| Website | https://www.scale.bio |
| Revenue | $13.1 million |
| Employees | 11 (11 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Scientific Instrumentation, Innovative Technology, Scientific Tools, Biotechnology, Life Sciences, Genomics, Bioinformatics, Molecular Biology, Cell Biology, Data Analysis, Experimental Design, High Throughput Screening, Drug Discovery, Biomedical Research, Genetic Analysis, Proteomics, Transcriptomics |
| Competitors | Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Illumina, Bio-Rad Laboratories, Nature Research (Publishing), 10x Genomics, Miltenyi Biotec, Takara Bio USA, Inc. +36 more (view full list) |
Looking for a particular Scale Biosciences employee's phone or email?
The Scale Biosciences annual revenue was $13.1 million in 2026.
Frank Steemers is the VP of R&D of Scale Biosciences.
11 people are employed at Scale Biosciences.
Scale Biosciences is based in San Diego, California.